Adolescents and young adults aged 15 to 39 years who are diagnosed with cancer (AYA survivors) undergo a range of therapies for cancer cure but subsequently may be at risk of treatment-related infertility, and for female AYA survivors, adverse pregnancy outcomes. Future fertility is important to AYA survivors. Meeting their fertility goals requires awareness of this importance, knowledge of cancer treatment–related fertility risks, appropriate fertility counseling on these risks, and access to fertility care. Epidemiologic and dissemination and implementation research are needed to estimate more precise risks of traditional and novel cancer therapies on fertility and pregnancy outcomes and improve the delivery of fertility care.
From the *Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, and
†Moores Cancer Center, University of California, San Diego; and
‡Pathology and Medicine, McMaster University, Hamilton, Ontario, Canada.
Support was provided by the National Institutes of Health (HD080952-04).
The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
Reprints: H. Irene Su, MD, MSCE, Moores UC San Diego Cancer Center, 3855 Health Sciences Dr, Dept 0901, La Jolla, CA 92093. E-mail: firstname.lastname@example.org.